FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness – NPR
NPR FDA Panel Endorses Gene Therapy For A Form Of Childhood BlindnessNPRA panel of experts has recommended that the Food and Drug Administration approve a treatment developed by Spark Therapeutics for a rare form of blindness. Spark Therapeutics hide caption. toggle caption. Spark Therapeutics. A panel of experts has …FDA Advisers Endorse Gene Therapy to Treat … Read more